首页>
外文期刊>clinical nuclear medicine
>Use of Fusion Images of I-131 Metaiodobenzylguanidine, SPECT, and Magnetic Resonance Studies to Identify a Malignant Pheochromocytoma
【24h】
Use of Fusion Images of I-131 Metaiodobenzylguanidine, SPECT, and Magnetic Resonance Studies to Identify a Malignant Pheochromocytoma
展开▼
机译:Use of Fusion Images of I-131 Metaiodobenzylguanidine, SPECT, and Magnetic Resonance Studies to Identify a Malignant Pheochromocytoma
Pheochromocytoma is a chromaffin tumor in which 10percnt; are extra-adrenal and 10percnt; are malignant. I-131 metaiodobenzylguanidine (MIBG) scintigraphy has an important role in the identification of these tumors and investigation of metastatic lesions. The authors describe a 36-year-old woman who underwent resection of a malignant left adrenal pheochromocytoma who was thought to have metastases in the liver and para-aortic lymph nodes. Fusion images of I-131 MIBG SPECT and magnetic resonance studies were obtained to properly identify the metastatic lesions. These fusion images helped greatly in subsequent surgery.
展开▼